Advanced search
Publication Cover
OncoImmunology Volume 6, 2017 - Issue 1
Submit an article Journal homepage
4,593
Views
160
CrossRef citations to date
0
Altmetric
Original Research

High NKG2A expression contributes to NK cell exhaustion and predicts a poor prognosis of patients with liver cancer

Cheng SunInstitute of Immunology, The Key Laboratory of Innate Immunity and Chronic Disease (Chinese Academy of Medical Science), School of Life Sciences and Medical Center, University of Science & Technology of China, Hefei, Anhui, China;Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, ChinaCorrespondence[email protected] [email protected]
,
Jing XuSun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangzhou, China
,
Qiang HuangAnhui Province Key Laboratory of Hepatopancreatobiliary Surgery, Anhui Provincial Hospital Affiliated to Anhui Medical University, Hefei, China
,
Mei HuangAnhui Province Key Laboratory of Hepatopancreatobiliary Surgery, Anhui Provincial Hospital Affiliated to Anhui Medical University, Hefei, China
,
Hao WenXinjiang Key Laboratory of Echinococcosis, Clinical Medical Research Institute, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
,
Chuanshan ZhangXinjiang Key Laboratory of Echinococcosis, Clinical Medical Research Institute, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
,
Jinyu WangInstitute of Immunology, The Key Laboratory of Innate Immunity and Chronic Disease (Chinese Academy of Medical Science), School of Life Sciences and Medical Center, University of Science & Technology of China, Hefei, Anhui, China
,
Jiaxi SongInstitute of Immunology, The Key Laboratory of Innate Immunity and Chronic Disease (Chinese Academy of Medical Science), School of Life Sciences and Medical Center, University of Science & Technology of China, Hefei, Anhui, China
,
Meijuan ZhengDepartment of Clinical Laboratory, First Affiliated Hospital of Anhui Medical University, Hefei, China
,
Haoyu SunInstitute of Immunology, The Key Laboratory of Innate Immunity and Chronic Disease (Chinese Academy of Medical Science), School of Life Sciences and Medical Center, University of Science & Technology of China, Hefei, Anhui, China
,
Haiming WeiInstitute of Immunology, The Key Laboratory of Innate Immunity and Chronic Disease (Chinese Academy of Medical Science), School of Life Sciences and Medical Center, University of Science & Technology of China, Hefei, Anhui, China
,
Weihua XiaoInstitute of Immunology, The Key Laboratory of Innate Immunity and Chronic Disease (Chinese Academy of Medical Science), School of Life Sciences and Medical Center, University of Science & Technology of China, Hefei, Anhui, China
,
Rui SunInstitute of Immunology, The Key Laboratory of Innate Immunity and Chronic Disease (Chinese Academy of Medical Science), School of Life Sciences and Medical Center, University of Science & Technology of China, Hefei, Anhui, China;Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China
&
Zhigang TianInstitute of Immunology, The Key Laboratory of Innate Immunity and Chronic Disease (Chinese Academy of Medical Science), School of Life Sciences and Medical Center, University of Science & Technology of China, Hefei, Anhui, China;Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, ChinaCorrespondence[email protected] [email protected]
 show all
Article: e1264562 | Received 01 Jul 2016, Accepted 17 Nov 2016, Published online: 07 Dec 2016

Citations (160)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Florencia Secchiari, Sol Yanel Nuñez, Jessica Mariel Sierra, Andrea Ziblat, María Victoria Regge, Ximena Lucía Raffo Iraolagoitia, Agustín Rovegno, Carlos Ameri, Fernando Pablo Secin, Nicolás Richards, Hernando Ríos Pita, Gonzalo Vitagliano, Luis Rico, Mauro Mieggi, Florencia Frascheri, Nicolás Bonanno, Leandro Blas, Aldana Trotta, Adrián David Friedrich, Mercedes Beatriz Fuertes, Carolina Inés Domaica & Norberto Walter Zwirner. (2022) The MICA-NKG2D axis in clear cell renal cell carcinoma bolsters MICA as target in immuno-oncology. OncoImmunology 11:1.
Read now
Giovanni Vitale, Stefano Gitto, Claudia Campani, Laura Turco, Anna Baldan, Fabio Marra & Maria Cristina Morelli. (2022) Biological therapies in patients with liver disease: are they really lifesavers?. Expert Opinion on Biological Therapy 22:4, pages 473-490.
Read now
Lihua Yu, Xiaoli Liu, Xinhui Wang, Fengna Yan, Peng Wang, Yuyong Jiang, Juan Du & Zhiyun Yang. (2021) TIGIT+ TIM-3+ NK cells are correlated with NK cell exhaustion and disease progression in patients with hepatitis B virus‑related hepatocellular carcinoma. OncoImmunology 10:1.
Read now
Huining Tian, Xiaoyu Zhu, You Lv, Yan Jiao & Guixia Wang. (2020) Glucometabolic Reprogramming in the Hepatocellular Carcinoma Microenvironment: Cause and Effect. Cancer Management and Research 12, pages 5957-5974.
Read now
Jing Chen, Dan-Xue Zheng, Xing-Juan Yu, Hong-Wei Sun, Yi-Tuo Xu, Yao-Jun Zhang & Jing Xu. (2019) Macrophages induce CD47 upregulation via IL-6 and correlate with poor survival in hepatocellular carcinoma patients. OncoImmunology 8:11.
Read now
Inga Hochnadel, Uta Kossatz-Boehlert, Nils Jedicke, Henrike Lenzen, Michael P. Manns & Tetyana Yevsa. (2017) Cancer vaccines and immunotherapeutic approaches in hepatobiliary and pancreatic cancers. Human Vaccines & Immunotherapeutics 13:12, pages 2931-2952.
Read now

Articles from other publishers (154)

Hao Zhang, Li Yang, Tingting Wang & Zhen Li. (2024) NK cell-based tumor immunotherapy. Bioactive Materials 31, pages 63-86.
Crossref
Duygu Ilke Cikman, Fehim Esen, Ayse Engin, Akif Turna, Melek Agkoc, Abdullah Yilmaz, Omer Faruk Saglam, Gunnur Deniz & Esin Cetin Aktas. (2023) Mediastinal lymph node removal modulates natural killer cell exhaustion in patients with non-small cell lung cancer. Immunologic Research 71:6, pages 959-971.
Crossref
Sarah Nersesian, Emily B. Carter, Stacey N. Lee, Lauren P. Westhaver & Jeanette E. Boudreau. (2023) Killer instincts: natural killer cells as multifactorial cancer immunotherapy. Frontiers in Immunology 14.
Crossref
Chenghu Song, Weici Liu, Guanyu Jiang, Zhao He, Ruixin Wang, Xiaokun Wang, Ruo Chen, Wenjun Mao & Shaojin Zhu. (2023) Identification and validation of a novel NK cells-related signature to predict prognosis and immune microenvironment in LUAD. Immunobiology 228:6, pages 152751.
Crossref
Maxime Borgeaud, Jose Sandoval, Michel Obeid, Giuseppe Banna, Olivier Michielin, Alfredo Addeo & Alex Friedlaender. (2023) Novel targets for immune-checkpoint inhibition in cancer. Cancer Treatment Reviews 120, pages 102614.
Crossref
Yao Rong, Yongfeng Wang, Mingzheng Tang, Guiqian Zhang, Yuan Yuan, Fengyuan Dong, Zhihang Wu, Guorong Ma, Songhua Liu, Xiashuang Zhao & Hui Cai. (2023) Comprehensive Pan-Cancer Analysis Reveals the Potential Biological, Immunological, and Prognostic Value of NKG2A. Analytical Cellular Pathology 2023, pages 1-28.
Crossref
Wanze Zhang, Bingxin Yu, Qingyu Meng, Luya Pu, Bin Liu & Fan Li. (2023) Novaferon gene modification promotes NK92 cell anti-tumor activity. International Immunopharmacology 122, pages 110613.
Crossref
Fei Tang, Jinhu Li, Lu Qi, Dongfang Liu, Yufei Bo, Shishang Qin, Yuhui Miao, Kezhuo Yu, Wenhong Hou, Jianan Li, Jirun Peng, Zhigang Tian, Linnan Zhu, Hui Peng, Dongfang Wang & Zemin Zhang. (2023) A pan-cancer single-cell panorama of human natural killer cells. Cell 186:19, pages 4235-4251.e20.
Crossref
Alice Mac Donald, Delphine Guipouy, William Lemieux, Mario Harvey, Louis-Jean Bordeleau, David Guay, Hugo Roméro, Yuanyi Li, Renaud Dion, Kathie Béland & Elie Haddad. (2023) KLRC1 knockout overcomes HLA-E-mediated inhibition and improves NK cell antitumor activity against solid tumors. Frontiers in Immunology 14.
Crossref
Congcong Zhao, Li Zhang, Zhe Zheng, Yongguo Li, Hongli Xiong, Ying Zhu, Qi Wang, Minzhu Zhao & Jianbo Li. (2023) Case report: sudden death following the administration of CAR-NK cells for lung cancer immunotherapy. Forensic Science, Medicine and Pathology.
Crossref
Valli De Re, Maria Lina Tornesello, Vito Racanelli, Marcella Prete & Agostino Steffan. (2023) Non-Classical HLA Class 1b and Hepatocellular Carcinoma. Biomedicines 11:6, pages 1672.
Crossref
Xiangqian Guan, Yuyan Lu, Yi Zhang, Ping Zhan, Zhigao Chen, Chuanzheng Wang & Zhenyu Yin. (2023) Tumor-associated NK cells facilitate tumor growth via NKp46 in immunocompetent murine hepatocellular carcinoma. Immunology Letters 258, pages 8-19.
Crossref
Shuojiong Pan, Jun Guan, Banruo Xianyu, Yizheng Tan, Tianyu Li & Huaping Xu. (2023) A Nanotherapeutic Strategy to Reverse NK Cell Exhaustion. Advanced Materials 35:23.
Crossref
Ming Zhao, Hui Huang, Feng He & Xiangsheng Fu. (2023) Current insights into the hepatic microenvironment and advances in immunotherapy for hepatocellular carcinoma. Frontiers in Immunology 14.
Crossref
Lihua Yu, Lei Sun, Xiaoli Liu, Xinhui Wang, Huiwen Yan, Qing Pu, Yuqing Xie, Yuyong Jiang, Juan Du & Zhiyun Yang. (2023) The imbalance between NKG2A and NKG2D expression is involved in NK cell immunosuppression and tumor progression of patients with hepatitis B virus‐related hepatocellular carcinoma. Hepatology Research 53:5, pages 417-431.
Crossref
Liping Wang, Zhe Chen, Guohong Liu & Yunbao Pan. (2023) Functional crosstalk and regulation of natural killer cells in tumor microenvironment: Significance and potential therapeutic strategies. Genes & Diseases 10:3, pages 990-1004.
Crossref
Ruonan Sun, Jiawei Li, Xianyi Lin, Yidong Yang, Bing Liu, Tianbi Lan, Shuang Xiao, Anyi Deng, Zhinan Yin, Yan Xu, Zheng Xiang & Bin Wu. (2023) Peripheral immune characteristics of hepatitis B virus-related hepatocellular carcinoma. Frontiers in Immunology 14.
Crossref
Wei Liu, Shuman Sheng, Chendi Zhu, Changzhong Li, Yonghui Zou, Chunrun Yang, Zi-Jiang Chen, Fei Wang & Xue Jiao. (2023) Increased NKG2A+CD8+ T-cell exhaustion in patients with adenomyosis. Mucosal Immunology 16:2, pages 121-134.
Crossref
Kai Zhang & Enwu Yuan. (2023) Combined analysis of bulk and single-cell RNA sequencing reveals novel natural killer cell-related prognostic biomarkers for predicting immunotherapeutic response in hepatocellular carcinoma. Frontiers in Immunology 14.
Crossref
María Florencia Mercogliano, Sofía Bruni, Florencia Luciana Mauro & Roxana Schillaci. (2023) Emerging Targeted Therapies for HER2-Positive Breast Cancer. Cancers 15:7, pages 1987.
Crossref
Kassandra M. Coyle, Lindsey G. Hawke & Mark L. Ormiston. (2023) Addressing Natural Killer Cell Dysfunction and Plasticity in Cell-Based Cancer Therapeutics. Cancers 15:6, pages 1743.
Crossref
Koen C. van Son, Lars Verschuren, Roeland Hanemaaijer, Helen Reeves, R. Bart Takkenberg, Joost P. H. Drenth, Maarten E. Tushuizen & Adriaan G. Holleboom. (2023) Non-Parenchymal Cells and the Extracellular Matrix in Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease. Cancers 15:4, pages 1308.
Crossref
Valentina Cazzetta, Delphine Depierreux, Francesco Colucci, Joanna Mikulak & Domenico Mavilio. (2023) NKG2A Immune Checkpoint in Vδ2 T Cells: Emerging Application in Cancer Immunotherapy. Cancers 15:4, pages 1264.
Crossref
YaWen CHEN, ZhiGang TIAN & Hui PENG. (2022) Heterogeneity of liver NK cells. SCIENTIA SINICA Vitae 53:2, pages 250-261.
Crossref
Jiacheng Bi, Chen Huang, Xiaomeng Jin, Chaoyue Zheng, Yingying Huang, Xiaohu Zheng, Zhigang Tian & Haoyu Sun. (2023) TIPE2 deletion improves the therapeutic potential of adoptively transferred NK cells . Journal for ImmunoTherapy of Cancer 11:2, pages e006002.
Crossref
Joshua K.M. Wong, Riccardo Dolcetti, Handoo Rhee, Fiona Simpson & Fernando Souza-Fonseca-Guimaraes. (2023) Weaponizing natural killer cells for solid cancer immunotherapy. Trends in Cancer 9:2, pages 111-121.
Crossref
Ysabel Alessa Schwietzer, Katharina Helene Susek, Ziqing Chen, Evren Alici & Arnika Kathleen Wagner. 2023. The Immunological Synapse – Part B. The Immunological Synapse – Part B 43 61 .
Emanuela Senjor, Meng-Wei Ko, Kawaljit Kaur, Po-Chun Chen, Barbara Breznik, Nishant Chovatiya, Janko Kos & Anahid Jewett. 2023. NK Cells in Cancer Immunotherapy: Successes and Challenges. NK Cells in Cancer Immunotherapy: Successes and Challenges 3 25 .
Chenyu Lin, Mitchell E. Horwitz & Lindsay A. M. Rein. (2022) Leveraging Natural Killer Cell Innate Immunity against Hematologic Malignancies: From Stem Cell Transplant to Adoptive Transfer and Beyond. International Journal of Molecular Sciences 24:1, pages 204.
Crossref
Camilla Volponi, Aurora Gazzillo & Eduardo Bonavita. (2022) The Tumor Microenvironment of Hepatocellular Carcinoma: Untying an Intricate Immunological Network. Cancers 14:24, pages 6151.
Crossref
Handi CaoSanxing GaoRitika JoganiRyohichi Sugimura. (2022) The Tumor Microenvironment Reprograms Immune Cells. Cellular Reprogramming 24:6, pages 343-352.
Crossref
Xinyu Wu & Sandro Matosevic. (2022) Gene-edited and CAR-NK cells: Opportunities and challenges with engineering of NK cells for immunotherapy. Molecular Therapy - Oncolytics 27, pages 224-238.
Crossref
Yuanbo Pan, Wei Tang, Wenpei Fan, Jianmin Zhang & Xiaoyuan Chen. (2022) Development of nanotechnology-mediated precision radiotherapy for anti-metastasis and radioprotection. Chemical Society Reviews 51:23, pages 9759-9830.
Crossref
Jack Fisher, Amber Doyle, Lara Graham, Salim Khakoo & Matthew Blunt. (2022) Disruption of the NKG2A:HLA-E Immune Checkpoint Axis to Enhance NK Cell Activation against Cancer. Vaccines 10:12, pages 1993.
Crossref
Jiani Xiao, Tianxiang Zhang, Fei Gao, Zhengwei Zhou, Guang Shu, Yizhou Zou & Gang Yin. (2022) Natural Killer Cells: A Promising Kit in the Adoptive Cell Therapy Toolbox. Cancers 14:22, pages 5657.
Crossref
Enrico Munari, Linda Quatrini, Cecilia Ciancaglini, Albino Eccher, Giuseppe Bogina, Lorenzo Moretta & Francesca Romana Mariotti. (2022) Immunotherapy targeting inhibitory checkpoints: The role of NK and other innate lymphoid cells. Seminars in Immunology 61-64, pages 101660.
Crossref
Junqi Wang, Xiaolin Liu, Tianqiang Jin, Yuqing Cao, Yu Tian & Feng Xu. (2022) NK cell immunometabolism as target for liver cancer therapy. International Immunopharmacology 112, pages 109193.
Crossref
Junming Ren, Yeara Jo, Lora K. Picton, Leon L. Su, David H. Raulet & K. Christopher Garcia. (2022) Induced CD45 Proximity Potentiates Natural Killer Cell Receptor Antagonism. ACS Synthetic Biology 11:10, pages 3426-3439.
Crossref
Dalila Mele, Greta Pessino, Giuseppe Trisolini, Alberto Luchena, Marco Benazzo, Patrizia Morbini, Stefania Mantovani, Barbara Oliviero, Mario U. Mondelli & Stefania Varchetta. (2022) Impaired intratumoral natural killer cell function in head and neck carcinoma. Frontiers in Immunology 13.
Crossref
Tamara J. Laskowski, Alexander Biederstädt & Katayoun Rezvani. (2022) Natural killer cells in antitumour adoptive cell immunotherapy. Nature Reviews Cancer 22:10, pages 557-575.
Crossref
Sophie Curio & Gabrielle T. Belz. (2022) The unique role of innate lymphoid cells in cancer and the hepatic microenvironment. Cellular & Molecular Immunology 19:9, pages 1012-1029.
Crossref
Xiaotong Wang, Huabao Xiong & Zhaochen Ning. (2022) Implications of NKG2A in immunity and immune-mediated diseases. Frontiers in Immunology 13.
Crossref
Jacob A. Myers, Dawn Schirm, Laura Bendzick, Rachel Hopps, Carly Selleck, Peter Hinderlie, Martin Felices & Jeffrey S. Miller. (2022) Balanced engagement of activating and inhibitory receptors mitigates human NK cell exhaustion. JCI Insight 7:15.
Crossref
Seyed Amir Sanatkar, Arash Heidari & Nima Rezaei. (2022) Cancer Immunotherapy: Diverse Approaches and Obstacles. Current Pharmaceutical Design 28:29, pages 2387-2403.
Crossref
Liuxin Yang, Yang Yang, Yang Chen, Yuhong Xu & Jinliang Peng. (2022) Cell-based drug delivery systems and their in vivo fate. Advanced Drug Delivery Reviews 187, pages 114394.
Crossref
Siyu Liu, Chang Xu, Fan Yang, Lu Zong, Yizu Qin, Yufeng Gao, Qian Su, Tuantuan Li, Ye Li, Yuanhong Xu & Meijuan Zheng. (2022) Natural Killer Cells Induce CD8+ T Cell Dysfunction via Galectin-9/TIM-3 in Chronic Hepatitis B Virus Infection. Frontiers in Immunology 13.
Crossref
Renata Moll-Bernardes, Sérgio C. Fortier, Andréa S. Sousa, Renato D. Lopes, Narendra Vera, Luciana Conde, André Feldman, Guilherme Arruda, Mauro Cabral-Castro, Denílson C. Albuquerque, Thiago C. Paula, Thyago Furquim, Vitor A. Loures, Karla Giusti, Nathália Oliveira, Ariane Macedo, Pedro Barros e Silva, Fábio De Luca, Marisol Kotsugai, Rafael Domiciano, Flávia A. Silva, Mayara F. Santos, Olga F. Souza, Fernando A. Bozza, Ronir R. Luiz & Emiliano Medei. (2022) NKG2A Expression among CD8 Cells Is Associated with COVID-19 Progression in Hypertensive Patients: Insights from the BRACE CORONA Randomized Trial. Journal of Clinical Medicine 11:13, pages 3713.
Crossref
Tahereh Hojjatipour, Saeed Aslani, Sevda Salimifard, Haleh Mikaeili, Maryam Hemmatzadeh, Jamshid Gholizadeh Navashenaq, Elham Ahangar Parvin, Farhad Jadidi-Niaragh & Hamed Mohammadi. (2022) NK cells - Dr. Jekyll and Mr. Hyde in autoimmune rheumatic diseases. International Immunopharmacology 107, pages 108682.
Crossref
Eimear Mylod, Joanne Lysaght & Melissa J. Conroy. (2022) Natural killer cell therapy: A new frontier for obesity-associated cancer. Cancer Letters 535, pages 215620.
Crossref
Maria Gemelli, Douglas M. Noonan, Valentina Carlini, Giuseppe Pelosi, Massimo Barberis, Riccardo Ricotta & Adriana Albini. (2022) Overcoming Resistance to Checkpoint Inhibitors: Natural Killer Cells in Non-Small Cell Lung Cancer. Frontiers in Oncology 12.
Crossref
Rosalia Busà, Matteo Bulati, Ester Badami, Giovanni Zito, Daniela Claudia Maresca, Pier Giulio Conaldi, Giuseppe Ercolano & Angela Ianaro. (2022) Tissue-Resident Innate Immune Cell-Based Therapy: A Cornerstone of Immunotherapy Strategies for Cancer Treatment. Frontiers in Cell and Developmental Biology 10.
Crossref
Alessandra Zecca, Valeria Barili, Andrea Olivani, Elisabetta Biasini, Carolina Boni, Paola Fisicaro, Ilaria Montali, Camilla Tiezzi, Raffaele Dalla Valle, Carlo Ferrari, Elisabetta Cariani & Gabriele Missale. (2022) Targeting Stress Sensor Kinases in Hepatocellular Carcinoma-Infiltrating Human NK Cells as a Novel Immunotherapeutic Strategy for Liver Cancer. Frontiers in Immunology 13.
Crossref
Dillon Corvino, Ananthi Kumar & Tobias Bald. (2022) Plasticity of NK cells in Cancer. Frontiers in Immunology 13.
Crossref
Hailey K. Carroll, Austin G. Duffy & Cliona O'Farrelly. (2022) Liver Immunology, Immunotherapy, and Liver Cancers: Time for a Rethink?. Seminars in Liver Disease 42:02, pages 212-224.
Crossref
Elena Melendez, Dafni Chondronasiou, Lluc Mosteiro, Jaime Martínez de Villarreal, Marcos Fernández-Alfara, Cian J. Lynch, Dirk Grimm, Francisco X. Real, José Alcamí, Núria Climent, Federico Pietrocola & Manuel Serrano. (2022) Natural killer cells act as an extrinsic barrier for in vivo reprogramming . Development 149:8.
Crossref
Ezgi Elmas, Noushin Saljoughian, Marcelo de Souza Fernandes Pereira, Brian P. Tullius, Kinnari Sorathia, Robin J. Nakkula, Dean A. Lee & Meisam Naeimi Kararoudi. (2022) CRISPR Gene Editing of Human Primary NK and T Cells for Cancer Immunotherapy. Frontiers in Oncology 12.
Crossref
Wanze Zhang, Zhenghua Zhao & Fan Li. (2022) Natural killer cell dysfunction in cancer and new strategies to utilize NK cell potential for cancer immunotherapy. Molecular Immunology 144, pages 58-70.
Crossref
Eimear Mylod, Ellen McKenna, Maria Davern, Martin P. Barr, Noel E. Donlon, Becky A. S. Bibby, Anshul Bhardwaj, John V. Reynolds, Joanne Lysaght, Stephen G. Maher & Melissa J. Conroy. (2022) Investigating the susceptibility of treatment-resistant oesophageal tumours to natural killer cell-mediated responses. Clinical and Experimental Medicine 23:2, pages 411-425.
Crossref
Adrià Archilla-Ortega, Carla Domuro, Juan Martin-Liberal & Purificación Muñoz. (2022) Blockade of novel immune checkpoints and new therapeutic combinations to boost antitumor immunity. Journal of Experimental & Clinical Cancer Research 41:1.
Crossref
Ondrej Venglar, Julio Rodriguez Bago, Benjamin Motais, Roman Hajek & Tomas Jelinek. (2022) Natural Killer Cells in the Malignant Niche of Multiple Myeloma. Frontiers in Immunology 12.
Crossref
Joey H. Li & Timothy E. O’Sullivan. (2022) Back to the Future: Spatiotemporal Determinants of NK Cell Antitumor Function. Frontiers in Immunology 12.
Crossref
Bhalchandra Mirlekar. (2022) Tumor promoting roles of IL-10, TGF-β, IL-4, and IL-35: Its implications in cancer immunotherapy. SAGE Open Medicine 10, pages 205031212110690.
Crossref
Lihua Yu, Xiaoli Liu, Xinhui Wang, Dongdong Zhou, Huiwen Yan, Yuqing Xie, Qing Pu, Ke Zhang & Zhiyun Yang. (2022) Nomogram for prediction of long-term survival with hepatocellular carcinoma based on NK cell counts. Annals of Hepatology, pages 100672.
Crossref
Josepmaria Argemi, Mariano Ponz-Sarvise & Bruno Sangro. 2022. Hepatobiliary Cancers: Translational Advances and Molecular Medicine. Hepatobiliary Cancers: Translational Advances and Molecular Medicine 367 413 .
Jack G. Fisher, Christopher J. Walker, Amber DP. Doyle, Peter WM. Johnson, Francesco Forconi, Mark S. Cragg, Yosef Landesman, Salim. I. Khakoo & Matthew D. Blunt. (2021) Selinexor Enhances NK Cell Activation Against Malignant B Cells via Downregulation of HLA-E. Frontiers in Oncology 11.
Crossref
Honghui Zeng, Le Wang, Jiajia Li, Siweier Luo, Qianqian Han, Fang Su, Jing Wei, Xiaona Wei, Jianping Wu, Bin Li, Jingang Huang, Patrick Tang, Chunwei Cao, Yiming Zhou & Qiongqiong Yang. (2021) Single-cell RNA-sequencing reveals distinct immune cell subsets and signaling pathways in IgA nephropathy. Cell & Bioscience 11:1.
Crossref
Zhaojun Pan, Ruiqiu Zhao, Yanxi Shen, Kai Liu, Wei Xue, Chengfei Liang, Mingli Peng, Peng Hu, Min Chen & Hongmei Xu. (2021) Low-frequency, exhausted immune status of CD56dim NK cells and disordered inflammatory cytokine secretion of CD56bright NK cells associated with progression of severe HFMD, especially in EV71-infected patients. International Immunopharmacology 101, pages 108369.
Crossref
Lingtong Zhi, Xin Su, Meichen Yin, Zikang Zhang, Hui Lu, Zhiyuan Niu, Changjiang Guo, Wuling Zhu & Xuan Zhang. (2021) Genetical engineering for NK and T cell immunotherapy with CRISPR/Cas9 technology: Implications and challenges. Cellular Immunology 369, pages 104436.
Crossref
Alessandro Pileri, Alba Guglielmo, Vieri Grandi, Silvia Alberti Violetti, Daniele Fanoni, Paolo Fava, Claudio Agostinelli, Emilio Berti, Pietro Quaglino & Nicola Pimpinelli. (2021) The Microenvironment’s Role in Mycosis Fungoides and Sézary Syndrome: From Progression to Therapeutic Implications. Cells 10:10, pages 2780.
Crossref
Ângelo Z Mattos, Jose D Debes, Andre Boonstra, Arndt Vogel & Angelo A Mattos. (2021) Immune aspects of hepatocellular carcinoma: From immune markers for early detection to immunotherapy. World Journal of Gastrointestinal Oncology 13:9, pages 1132-1143.
Crossref
E Hui Clarissa Lee, Darren Chen Pei Wong & Jeak Ling Ding. (2021) NK Cells in a Tug-of-War With Cancer: The Roles of Transcription Factors and Cytoskeleton. Frontiers in Immunology 12.
Crossref
Yongqin Zeng, Xiuzhi Lv & Juan Du. (2021) Natural killer cell‑based immunotherapy for lung cancer: Challenges and perspectives (Review). Oncology Reports 46:5.
Crossref
Shahenda Mahgoub, Hadeer Abosalem, Mohamed Emara, Nahla Kotb, A. Maged & Sameh Soror. (2021) Restoring NK cells functionality via cytokine activation enhances cetuximab-mediated NK-cell ADCC: A promising therapeutic tool for HCC patients. Molecular Immunology 137, pages 221-227.
Crossref
Xiangyu Meng, Yunfeng Lei, Xuezhong Zhang, Kai Sun, Liming Zhang & Zhifei Wang. (2021) Cancer immunotherapy: Classification, therapeutic mechanisms, and nanomaterial-based synergistic therapy. Applied Materials Today 24, pages 101149.
Crossref
Zhulin Wu, Li He, Lina Yang, Xuehong Fang & Lisheng Peng. (2021) Potential Role of NEU1 in Hepatocellular Carcinoma: A Study Based on Comprehensive Bioinformatical Analysis. Frontiers in Molecular Biosciences 8.
Crossref
Nicolas Jacquelot, Cyril Seillet, Fernando Souza-Fonseca-Guimaraes, Adrian G. Sacher, Gabrielle T. Belz & Pamela S. Ohashi. (2021) Natural Killer Cells and Type 1 Innate Lymphoid Cells in Hepatocellular Carcinoma: Current Knowledge and Future Perspectives. International Journal of Molecular Sciences 22:16, pages 9044.
Crossref
Haipeng Zhu & Xiaojun Liu. (2021) Advances of Tumorigenesis, Diagnosis at Early Stage, and Cellular Immunotherapy in Gastrointestinal Malignancies. Frontiers in Oncology 11.
Crossref
Hadeer Abosalem, Shahenda Mahgoub, Mohamed Emara, Nahla Kotb & Sameh Soror. (2021) Interrupted Crosstalk between Natural Killer Cells and Anti-epidermal Growth Factor Receptor: A Possible Role in Hepatocellular Carcinoma Treatment Failure. Current Cancer Drug Targets 21:7, pages 601-607.
Crossref
Lucila N. Kerbauy, Nancy D. Marin, Mecit Kaplan, Pinaki P. Banerjee, Melissa M. Berrien-Elliott, Michelle Becker-Hapak, Rafet Basar, Mark Foster, Luciana Garcia Melo, Carly C. Neal, Ethan McClain, May Daher, Ana Karen Nunez Cortes, Sweta Desai, Francesca Wei Inng Lim, Mayela Carolina Mendt, Timothy Schappe, Li Li, Hila Shaim, Mayra Shanley, Emily L. Ensley, Nadima Uprety, Pamela Wong, Enli Liu, Sonny O. Ang, Rong Cai, Vandana Nandivada, Vakul Mohanty, Qi Miao, Yifei Shen, Natalia Baran, Natalie W. Fowlkes, Ken Chen, Luis Muniz-Feliciano, Richard E. Champlin, Yago L. Nieto, Joachim Koch, Martin Treder, Wolfgang Fischer, Oswaldo Keith Okamoto, Elizabeth J. Shpall, Todd A. Fehniger & Katayoun Rezvani. (2021) Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood–Derived NK Cells Facilitates CAR-like Responses Against CD30+ Malignancies. Clinical Cancer Research 27:13, pages 3744-3756.
Crossref
Dorota M. Radomska-Leśniewska, Agata Białoszewska & Paweł Kamiński. (2021) Angiogenic Properties of NK Cells in Cancer and Other Angiogenesis-Dependent Diseases. Cells 10:7, pages 1621.
Crossref
Rachel Elizabeth Ann Fincham, Francesca Romana Delvecchio, Michelle R Goulart, Joe Poe Sheng Yeong & Hemant M Kocher. (2021) Natural killer cells in pancreatic cancer stroma. World Journal of Gastroenterology 27:24, pages 3483-3501.
Crossref
Natasha Mupeta Kaweme & Fuling Zhou. (2021) Optimizing NK Cell-Based Immunotherapy in Myeloid Leukemia: Abrogating an Immunosuppressive Microenvironment. Frontiers in Immunology 12.
Crossref
Yuichi Yoshida, Sachiyo Yoshio, Taiji Yamazoe, Taizo Mori, Yuriko Tsustui, Hironari Kawai, Shiori Yoshikawa, Takasuke Fukuhara, Toru Okamoto, Yoshihiro Ono, Yu Takahashi, Ryuki Hashida, Takumi Kawaguchi, Akinobu Taketomi & Tatsuya Kanto. (2021) Phenotypic Characterization by Single-Cell Mass Cytometry of Human Intrahepatic and Peripheral NK Cells in Patients with Hepatocellular Carcinoma. Cells 10:6, pages 1495.
Crossref
Namita Varudkar, Jeremiah L Oyer, Alicja Copik & Griffith D Parks. (2021) Oncolytic parainfluenza virus combines with NK cells to mediate killing of infected and non-infected lung cancer cells within 3D spheroids: role of type I and type III interferon signaling. Journal for ImmunoTherapy of Cancer 9:6, pages e002373.
Crossref
Aaron T. Ciner, Keaton Jones, Ruth J. Muschel & Pnina Brodt. (2021) The unique immune microenvironment of liver metastases: Challenges and opportunities. Seminars in Cancer Biology 71, pages 143-156.
Crossref
Eric Alves, Shahama Taifour, Riccardo Dolcetti, Jonathan Chee, Anna K. Nowak, Silvana Gaudieri & Pilar Blancafort. (2021) Reprogramming the anti-tumor immune response via CRISPR genetic and epigenetic editing. Molecular Therapy - Methods & Clinical Development 21, pages 592-606.
Crossref
Raynier Devillier, Anne-Sophie Chrétien, Thomas Pagliardini, Nassim Salem, Didier Blaise & Daniel Olive. (2021) Mechanisms of NK cell dysfunction in the tumor microenvironment and current clinical approaches to harness NK cell potential for immunotherapy. Journal of Leukocyte Biology 109:6, pages 1071-1088.
Crossref
Arshi Khanam, Joel V. Chua & Shyam Kottilil. (2021) Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease Progression. International Journal of Molecular Sciences 22:11, pages 5497.
Crossref
Valentina Cazzetta, Sara Franzese, Claudia Carenza, Silvia Della Bella, Joanna Mikulak & Domenico Mavilio. (2021) Natural Killer–Dendritic Cell Interactions in Liver Cancer: Implications for Immunotherapy. Cancers 13:9, pages 2184.
Crossref
Hui Sun, Yuzhang Wu, Yi Zhang & Bing Ni. (2021) IL-10-Producing ILCs: Molecular Mechanisms and Disease Relevance. Frontiers in Immunology 12.
Crossref
Hansol Lee, Inês Pires Da Silva, Umaimainthan Palendira, Richard A. Scolyer, Georgina V. Long & James S. Wilmott. (2021) Targeting NK Cells to Enhance Melanoma Response to Immunotherapies. Cancers 13:6, pages 1363.
Crossref
Alessandra Zecca, Valeria Barili, Danila Rizzo, Andrea Olivani, Elisabetta Biasini, Diletta Laccabue, Raffaele Dalla Valle, Carlo Ferrari, Elisabetta Cariani & Gabriele Missale. (2021) Intratumor Regulatory Noncytotoxic NK Cells in Patients with Hepatocellular Carcinoma. Cells 10:3, pages 614.
Crossref
Phillip Spinosa, Monika Musial‐Siwek, Marc Presler, Alison Betts, Emily Rosentrater, Janice Villali, Lucia Wille, Yang Zhao, Tom McCaughtry, Kalyanasundaram Subramanian & Hanlan Liu. (2021) Quantitative modeling predicts competitive advantages of a next generation anti‐NKG2A monoclonal antibody over monalizumab for the treatment of cancer. CPT: Pharmacometrics & Systems Pharmacology 10:3, pages 220-229.
Crossref
Johanna Bödder, Tasmin Zahan, Rianne van Slooten, Gerty Schreibelt, I. Jolanda M. de Vries & Georgina Flórez-Grau. (2021) Harnessing the cDC1-NK Cross-Talk in the Tumor Microenvironment to Battle Cancer. Frontiers in Immunology 11.
Crossref
Guangyong Sun, Xinyan Zhao, Mingyang Li, Chunpan Zhang, Hua Jin, Changying Li, Liwei Liu, Yaning Wang, Wen Shi, Dan Tian, Hufeng Xu, Yue Tian, Yongle Wu, Kai Liu, Zhongtao Zhang & Dong Zhang. (2021) CD4 derived double negative T cells prevent the development and progression of nonalcoholic steatohepatitis. Nature Communications 12:1.
Crossref
Ze-Long Liu, Jing-Hua Liu, Daniel Staiculescu & Jiang Chen. (2021) Combination of molecularly targeted therapies and immune checkpoint inhibitors in the new era of unresectable hepatocellular carcinoma treatment. Therapeutic Advances in Medical Oncology 13, pages 175883592110180.
Crossref
Beatriz Cózar, Marco Greppi, Sabrina Carpentier, Emilie Narni-Mancinelli, Laura Chiossone & Eric Vivier. (2021) Tumor-Infiltrating Natural Killer Cells. Cancer Discovery 11:1, pages 34-44.
Crossref
Yongyan Chen & Zhigang Tian. (2020) Innate lymphocytes: pathogenesis and therapeutic targets of liver diseases and cancer. Cellular & Molecular Immunology 18:1, pages 57-72.
Crossref
Ling Wang, Zheng Kuang, Duo Zhang, Yifan Gao, Mingzhen Ying & Tengjiao Wang. (2021) Reactive oxygen species in immune cells: A new antitumor target. Biomedicine & Pharmacotherapy 133, pages 110978.
Crossref
Rosa Nguyen & Wayne L. Furman. 2021. Successes and Challenges of NK Immunotherapy. Successes and Challenges of NK Immunotherapy 405 437 .
Sumera Rizvi, Juan Wang & Anthony B. El‐Khoueiry. (2020) Liver Cancer Immunity. Hepatology 73:S1, pages 86-103.
Crossref
Minhong Shen & Yibin Kang. (2020) Stresses in the metastatic cascade: molecular mechanisms and therapeutic opportunities. Genes & Development 34:23-24, pages 1577-1598.
Crossref
Sahak Z. Makaryan & Stacey D. Finley. (2020) An optimal control approach for enhancing natural killer cells' secretion of cytolytic molecules. APL Bioengineering 4:4.
Crossref
Weizhi Chen, Yang Yuan & Xiqun Jiang. (2020) Antibody and antibody fragments for cancer immunotherapy. Journal of Controlled Release 328, pages 395-406.
Crossref
M. Marotel, M.S. Hasim, A. Hagerman & M. Ardolino. (2020) The two-faces of NK cells in oncolytic virotherapy. Cytokine & Growth Factor Reviews 56, pages 59-68.
Crossref
Silvia Pesce, Sara Trabanelli, Clara Di Vito, Marco Greppi, Valentina Obino, Fabio Guolo, Paola Minetto, Matteo Bozzo, Michela Calvi, Elisa Zaghi, Simona Candiani, Roberto Massimo Lemoli, Camilla Jandus, Domenico Mavilio & Emanuela Marcenaro. (2020) Cancer Immunotherapy by Blocking Immune Checkpoints on Innate Lymphocytes. Cancers 12:12, pages 3504.
Crossref
Helmi Alfarra, Jackson Weir, Stacy Grieve & Tony Reiman. (2020) Targeting NK Cell Inhibitory Receptors for Precision Multiple Myeloma Immunotherapy. Frontiers in Immunology 11.
Crossref
Yuqing Cao, Xiaoyu Wang, Tianqiang Jin, Yu Tian, Chaoliu Dai, Crystal Widarma, Rui Song & Feng Xu. (2020) Immune checkpoint molecules in natural killer cells as potential targets for cancer immunotherapy. Signal Transduction and Targeted Therapy 5:1.
Crossref
Tobias Bald, Matthew F. Krummel, Mark J. Smyth & Kevin C. Barry. (2020) The NK cell–cancer cycle: advances and new challenges in NK cell–based immunotherapies. Nature Immunology 21:8, pages 835-847.
Crossref
Jiao Wang & Sandro Matosevic. (2020) Functional and metabolic targeting of natural killer cells to solid tumors. Cellular Oncology 43:4, pages 577-600.
Crossref
L Tao, S Wang, L Yang, L Jiang, J Li & X Wang. (2020) Reduced Siglec-7 expression on NK cells predicts NK cell dysfunction in primary hepatocellular carcinoma. Clinical and Experimental Immunology 201:2, pages 161-170.
Crossref
Luana Guerra, Lynn Bonetti & Dirk Brenner. (2020) Metabolic Modulation of Immunity: A New Concept in Cancer Immunotherapy. Cell Reports 32:1, pages 107848.
Crossref
Cai Zhang & Yuxia Liu. (2020) Targeting NK Cell Checkpoint Receptors or Molecules for Cancer Immunotherapy. Frontiers in Immunology 11.
Crossref
Qingqing Ma, Xiaoyu Dong, Siyu Liu, Tao Zhong, Dandan Sun, Lu Zong, Changcheng Zhao, Qiong Lu, Min Zhang, Yufeng Gao, Ying Ye, Jun Cheng, Yuanhong Xu & Meijuan Zheng. (2020) Hepatitis B e Antigen Induces NKG2A+ Natural Killer Cell Dysfunction via Regulatory T Cell-Derived Interleukin 10 in Chronic Hepatitis B Virus Infection. Frontiers in Cell and Developmental Biology 8.
Crossref
Christian Sordo-Bahamonde, Seila Lorenzo-Herrero, Ángel R. Payer, Segundo Gonzalez & Alejandro López-Soto. (2020) Mechanisms of Apoptosis Resistance to NK Cell-Mediated Cytotoxicity in Cancer. International Journal of Molecular Sciences 21:10, pages 3726.
Crossref
Raquel Tarazona, Nelson Lopez-Sejas, Beatriz Guerrero, Fakhri Hassouneh, Isabel Valhondo, Alejandra Pera, Beatriz Sanchez-Correa, Nieves Pastor, Esther Duran, Corona Alonso & Rafael Solana. (2020) Current progress in NK cell biology and NK cell-based cancer immunotherapy. Cancer Immunology, Immunotherapy 69:5, pages 879-899.
Crossref
Kristen Solocinski, Michelle R Padget, Kellsye P Fabian, Benjamin Wolfson, Fabiola Cecchi, Todd Hembrough, Stephen C Benz, Shahrooz Rabizadeh, Patrick Soon-Shiong, Jeffrey Schlom & James W Hodge. (2020) Overcoming hypoxia-induced functional suppression of NK cells. Journal for ImmunoTherapy of Cancer 8:1, pages e000246.
Crossref
Shiqian Gao, Tianyu Li, Ye Guo, Chenxing Sun, Banruo Xianyu & Huaping Xu. (2020) Selenium‐Containing Nanoparticles Combine the NK Cells Mediated Immunotherapy with Radiotherapy and Chemotherapy. Advanced Materials 32:12.
Crossref
Aviad Ben-Shmuel, Guy Biber & Mira Barda-Saad. (2020) Unleashing Natural Killer Cells in the Tumor Microenvironment–The Next Generation of Immunotherapy?. Frontiers in Immunology 11.
Crossref
Cai Zhang, Yuan Hu & Chongdeng Shi. (2020) Targeting Natural Killer Cells for Tumor Immunotherapy. Frontiers in Immunology 11.
Crossref
Muhammad Khan, Sumbal Arooj & Hua Wang. (2020) NK Cell-Based Immune Checkpoint Inhibition. Frontiers in Immunology 11.
Crossref
Chaopin Yang, Yue Li, Yaozhang Yang & Zhiyi Chen. (2020) Overview of Strategies to Improve Therapy against Tumors Using Natural Killer Cell. Journal of Immunology Research 2020, pages 1-16.
Crossref
Luo Qizhi, Luo Weiguang, Zhu Quan, Huang Hongjun, Peng Huiyun, Liu Rongjiao, Xie Min, Li Shili, Li Ming, Hu Xiaocui & Zou Yizhou. (2020) Tumor-Derived Soluble MICA Obstructs the NKG2D Pathway to Restrain NK Cytotoxicity. Aging and disease 11:1, pages 118.
Crossref
Meijuan Zheng & Zhigang Tian. (2019) Liver-Mediated Adaptive Immune Tolerance. Frontiers in Immunology 10.
Crossref
Haoyu Sun & Cheng Sun. (2019) The Rise of NK Cell Checkpoints as Promising Therapeutic Targets in Cancer Immunotherapy. Frontiers in Immunology 10.
Crossref
Anna V. Tinker, Holger W. Hirte, Diane Provencher, Marcus Butler, Heather Ritter, Dongsheng Tu, Hatem A. AzimJrJr, Paulo Paralejas, Nathalie Grenier, Shirley-Ann Hahn, Janelle Ramsahai & Lesley Seymour. (2019) Dose-Ranging and Cohort-Expansion Study of Monalizumab (IPH2201) in Patients with Advanced Gynecologic Malignancies: A Trial of the Canadian Cancer Trials Group (CCTG): IND221. Clinical Cancer Research 25:20, pages 6052-6060.
Crossref
Lukman O. Afolabi, Adeleye O. Adeshakin, Musbahu M. Sani, Jiacheng Bi & Xiaochun Wan. (2019) Genetic reprogramming for NK cell cancer immunotherapy with CRISPR/Cas9. Immunology 158:2, pages 63-69.
Crossref
Sizhe Liu, Payal Dhar & Jennifer D. Wu. (2019) NK Cell Plasticity in Cancer. Journal of Clinical Medicine 8:9, pages 1492.
Crossref
Bilikis Aderonke Abolarinwa, Ridwan Babatunde Ibrahim & Yen-Hua Huang. (2019) Conceptual Development of Immunotherapeutic Approaches to Gastrointestinal Cancer. International Journal of Molecular Sciences 20:18, pages 4624.
Crossref
Jonathan J. Hodgins, Sarwat T. Khan, Maria M. Park, Rebecca C. Auer & Michele Ardolino. (2019) Killers 2.0: NK cell therapies at the forefront of cancer control. Journal of Clinical Investigation 129:9, pages 3499-3510.
Crossref
Pulak Ranjan Nath, Dipasmita Pal-Nath, Ajeet Mandal, Margaret C. Cam, Anthony L. Schwartz & David D. Roberts. (2019) Natural Killer Cell Recruitment and Activation Are Regulated by CD47 Expression in the Tumor Microenvironment. Cancer Immunology Research 7:9, pages 1547-1561.
Crossref
Elisabetta Cariani & Gabriele Missale. (2019) Immune landscape of hepatocellular carcinoma microenvironment: Implications for prognosis and therapeutic applications. Liver International 39:9, pages 1608-1621.
Crossref
Julián Piñeiro Fernández, Kimberly A. Luddy, Cathal Harmon & Cliona O’Farrelly. (2019) Hepatic Tumor Microenvironments and Effects on NK Cell Phenotype and Function. International Journal of Molecular Sciences 20:17, pages 4131.
Crossref
Shembrey, Huntington & Hollande. (2019) Impact of Tumor and Immunological Heterogeneity on the Anti-Cancer Immune Response. Cancers 11:9, pages 1217.
Crossref
Jiacheng Bi & Zhigang Tian. (2019) NK Cell Dysfunction and Checkpoint Immunotherapy. Frontiers in Immunology 10.
Crossref
Olivier Lucar, R. Keith Reeves & Stephanie Jost. (2019) A Natural Impact: NK Cells at the Intersection of Cancer and HIV Disease. Frontiers in Immunology 10.
Crossref
Chen Han, Yongjie Jiang, Zhaoxia Wang & Hengxiao Wang. (2019) Natural killer cells involved in tumour immune escape of hepatocellular carcinomar. International Immunopharmacology 73, pages 10-16.
Crossref
Edo Kon & Itai Benhar. (2019) Immune checkpoint inhibitor combinations: Current efforts and important aspects for success. Drug Resistance Updates 45, pages 13-29.
Crossref
Nayoung Kim, Hyeon Ho Lee, Hyo-Jung Lee, Woo Seon Choi, Jinju Lee & Hun Sik Kim. (2019) Natural killer cells as a promising therapeutic target for cancer immunotherapy. Archives of Pharmacal Research 42:7, pages 591-606.
Crossref
Hyung-Don Kim & Su-Hyung Park. (2019) Immunological and clinical implications of immune checkpoint blockade in human cancer. Archives of Pharmacal Research 42:7, pages 567-581.
Crossref
Haoyu Sun, Qiang Huang, Mei Huang, Hao Wen, Renyong Lin, Meijuan Zheng, Kun Qu, Kun Li, Haiming Wei, Weihua Xiao, Rui Sun, Zhigang Tian & Cheng Sun. (2019) Human CD96 Correlates to Natural Killer Cell Exhaustion and Predicts the Prognosis of Human Hepatocellular Carcinoma. Hepatology 70:1, pages 168-183.
Crossref
Jiangang Zhao, Hans A. Schlößer, Zhefang Wang, Jie Qin, Jiahui Li, Felix Popp, Marie Christine Popp, Hakan Alakus, Seung-Hun Chon, Hinrich P. Hansen, Wolfram F. Neiss, Karl-Walter Jauch, Christiane J. Bruns & Yue Zhao. (2019) Tumor-Derived Extracellular Vesicles Inhibit Natural Killer Cell Function in Pancreatic Cancer. Cancers 11:6, pages 874.
Crossref
Elisa Zaghi, Michela Calvi, Emanuela Marcenaro, Domenico Mavilio & Clara Di Vito. (2019) Targeting NKG2A to elucidate natural killer cell ontogenesis and to develop novel immune-therapeutic strategies in cancer therapy. Journal of Leukocyte Biology 105:6, pages 1243-1251.
Crossref
Adriana Gutiérrez-Hoya, Octavio Zerecero-Carreón, Arturo Valle-Mendiola, Martha Moreno-Lafont, Rubén López-Santiago, Benny Weiss-Steider & Isabel Soto-Cruz. (2019) Cervical Cancer Cells Express Markers Associated with Immunosurveillance. Journal of Immunology Research 2019, pages 1-10.
Crossref
Joanna Mikulak, Elena Bruni, Ferdinando Oriolo, Clara Di Vito & Domenico Mavilio. (2019) Hepatic Natural Killer Cells: Organ-Specific Sentinels of Liver Immune Homeostasis and Physiopathology. Frontiers in Immunology 10.
Crossref
Stefania Mantovani, Barbara Oliviero, Andrea Lombardi, Stefania Varchetta, Dalila Mele, Angelo Sangiovanni, Giorgio Rossi, Matteo Donadon, Guido Torzilli, Cristiana Soldani, Camillo Porta, Paolo Pedrazzoli, Silvia Chiellino, Roberto Santambrogio, Enrico Opocher, Marcello Maestri, Stefano Bernuzzi, Armando Rossello, Sophie Clément, Claudio De Vito, Laura Rubbia‐Brandt, Francesco Negro & Mario U. Mondelli. (2019) Deficient Natural Killer Cell NKp30‐Mediated Function and Altered NCR3 Splice Variants in Hepatocellular Carcinoma. Hepatology 69:3, pages 1165-1179.
Crossref
Yuan Hu, Zhigang Tian & Cai Zhang. (2019) Natural Killer Cell-Based Immunotherapy for Cancer: Advances and Prospects. Engineering 5:1, pages 106-114.
Crossref
Li-Juan Hu, Xiang-Yu Zhao, Xing-Xing Yu, Meng Lv, Ting-Ting Han, Wei Han & Xiao-Jun Huang. (2019) Quantity and Quality Reconstitution of NKG2A+ Natural Killer Cells Are Associated with Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation 25:1, pages 1-11.
Crossref
Haoyu Sun, Jing Xu, Qiang Huang, Mei Huang, Kun Li, Kun Qu, Hao Wen, Renyong Lin, Meijuan Zheng, Haiming Wei, Weihua Xiao, Rui Sun, Zhigang Tian & Cheng Sun. (2018) Reduced CD160 Expression Contributes to Impaired NK-cell Function and Poor Clinical Outcomes in Patients with HCC. Cancer Research 78:23, pages 6581-6593.
Crossref
Nayoung Kim & Hun Sik Kim. (2018) Targeting Checkpoint Receptors and Molecules for Therapeutic Modulation of Natural Killer Cells. Frontiers in Immunology 9.
Crossref
Meijuan Zheng, Haoyu Sun & Zhigang Tian. (2018) Natural killer cells in liver diseases. Frontiers of Medicine 12:3, pages 269-279.
Crossref
Marc Ringelhan, Dominik Pfister, Tracy O’Connor, Eli Pikarsky & Mathias Heikenwalder. (2018) The immunology of hepatocellular carcinoma. Nature Immunology 19:3, pages 222-232.
Crossref
Hwan Hee Lee, Hyojeung Kang & Hyosun Cho. (2017) Natural killer cells and tumor metastasis. Archives of Pharmacal Research 40:9, pages 1037-1049.
Crossref
Jiacheng Bi & Zhigang Tian. (2017) NK Cell Exhaustion. Frontiers in Immunology 8.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.